Synthesis and SAR of novel, 4-(phenylsulfamoyl)phenylacetamide mGlu4 positive allosteric modulators (PAMs) identified by functional high-throughput screening (HTS)

被引：26

作者：

Engers, Darren W. ^{[1
,2
]}

Gentry, Patrick R. ^{[1
,2
]}

Williams, Richard ^{[1
,2
]}

Bolinger, Julie D. ^{[1
]}

Weaver, C. David ^{[1
,2
]}

Menon, Usha N. ^{[1
]}

Conn, P. Jeffrey ^{[1
,2
]}

Lindsley, Craig W. ^{[1
,2
,3
]}

Niswender, Colleen M. ^{[1
,2
]}

Hopkins, Corey R. ^{[1
,2
]}

机构：

[1] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA

[2] Vanderbilt Program Drug Discovery, Nashville, TN 37232 USA

[3] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 17期

关键词：

mGlu; Metabotropic glutamate receptor 4; Functional high-throughput screen (HTS); GLUTAMATE-RECEPTOR; 4; PARKINSONS-DISEASE; MGLUR4; PHARMACOLOGY; DISCOVERY;

D O I：

10.1016/j.bmcl.2010.07.007

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Herein we disclose the synthesis and SAR of a series of 4-(phenylsulfamoyl)phenylacetamide compounds as mGlu(4) positive allosteric modulators (PAMs) that were identified via a functional HTS. An iterative parallel approach to these compounds culminated in the discovery of VU0364439 (11) which represents the most potent (19.8 nM) mGlu(4) PAM reported to date. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：5175 / 5178

页数：4

共 20 条

[1] Bolea C., 2009, Patent, Patent No. [WO2009010455A2, 2009010455]
[2] Bolea C., 2009, Patent, Patent No. [WO2009010454 A2, 2009010454]
[3] Conn P J., 1994, The metabotropic glutamate receptors
[4] Pharmacology and functions of metabotropic glutamate receptors
Conn, PJ
Pin, JP
[J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 : 205 - 237
[5] Synthesis and Evaluation of a Series of Heterobiarylamides That Are Centrally Penetrant Metabotropic Glutamate Receptor 4 (mGluR4) Positive Allosteric Modulators (PAMs)
Engers, Darren W.
Niswender, Colleen M.
Weaver, C. David
Jadhav, Satyawan
Menon, Usha N.
Zamorano, Rocio
Conn, P. Jeffrey
Lindsley, Craig W.
Hopkins, Corey R.
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (14) : 4115 - 4118
[6] mGluR4-positive allosteric modulation as potential treatment for Parkinson's disease
Hopkins, Corey R.
Lindsley, Craig W.
Niswender, Colleen M.
[J]. FUTURE MEDICINAL CHEMISTRY, 2009, 1 (03) : 501 - 513
[7] Development of a custom high-throughput preparative liquid chromatography/mass spectrometer platform for the preparative purification and analytical analysis of compound libraries
Leister, W
Strauss, K
Wisnoski, D
Zhao, ZJ
Lindsley, C
[J]. JOURNAL OF COMBINATORIAL CHEMISTRY, 2003, 5 (03): : 322 - 329
[8] Lindsley CW, 2009, CURR TOP MED CHEM, V9, P949
[9] (-)-PHCCC, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and neuroprotection
Maj, M
Bruno, V
Dragic, Z
Yamamoto, R
Battaglia, G
Inderbitzin, W
Stoehr, N
Stein, T
Gasparini, F
Vranesic, I
Kuhn, R
Nicoletti, F
Flor, PJ
[J]. NEUROPHARMACOLOGY, 2003, 45 (07) : 895 - 906
[10] Allosteric modulation of group III metabotropic glutamate receptor 4: A potential approach to Parkinson's disease treatment
Marino, MJ
Williams, DL
O'Brien, JA
Valenti, O
McDonald, TP
Clements, MK
Wang, RP
DiLella, AG
Hess, JF
Kinney, GG
Conn, PJ
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (23) : 13668 - 13673

← 1 2 →